Series A Investors & VC Firms in Belgium

77 firms in this list, with a median first check of $540K. 4 of them lead rounds. Generated from verified public data and updated continuously.

Fund	FoxScore	HQ	Invests	Stage	Check	CRM
CU Curiosity VC VBHKMBH22 people	88🔒	Benelux	BE	Seed–Series A	—	+ Add to CRM
EL Elaia ACEPFDMR11 people	88🔒	Paris	FR	Seed–Growth	$108K – $1.6M	+ Add to CRM
XA XAnge	88🔒	Paris	FR	Pre-Seed–Series B	—	+ Add to CRM
MO Moonfire Ventures MLAGMAAP14 people	88🔒	St Peter Port, Guernsey	GB	Seed–Series A	—	+ Add to CRM
AN Angelwise JVMMMBG24 people · Leads rounds	88🔒	—	BE	Seed–Series A	$200K – $600K	+ Add to CRM
NE Newion JVPPFCMD10 people · Follows rounds	88🔒	Amsterdam	NL	Seed–Late Stage	$1.1M – $11M	+ Add to CRM
CO Cottonwood Technology Fund ALDBLRPC12 people · Leads rounds	88🔒	Denver	US	Pre-Seed–Growth	$1M – $3M	+ Add to CRM
VE Ventech ACASCCCH10 people	88🔒	Paris	FR	Seed–Growth	$540K – $5.4M	+ Add to CRM
MO Motive Partners Leads rounds	88🔒	New York	US	Pre-Seed–Late Stage	$1M – $10M	+ Add to CRM
FI Finch Capital AGFRMBRV9 people · Leads rounds	88🔒	Amsterdam	NL	Series A–Growth	$5.4M – $16.2M	+ Add to CRM
AT Atomico NZAHBBCB11 people	88🔒	London	GB	Seed–Late Stage	—	+ Add to CRM
EN ENGIE New Ventures JBCCLRSP6 people	88🔒	Paris	FR	Seed–Late Stage	$1.1M – $5.4M	+ Add to CRM
FO Fortino Capital DSFVIKJV11 people	88🔒	Antwerp	BE	Seed–Late Stage	$540K – $32.4M	+ Add to CRM
B2 b2venture FSAGCSGJ11 people	88🔒	Berlin	DE	Pre-Seed–Late Stage	$270K – $5.4M	+ Add to CRM
DA Dawn Capital LLP DCEPHOHM11 people	88🔒	London	GB	Series A–Series B	$317.5K – $6.3M	+ Add to CRM
EQ EQT Life Sciences APFVFAJR11 people	88🔒	Amsterdam	NL	Series A–Late Stage	$10.8M – $64.8M	+ Add to CRM
GI Gilde Healthcare AFEDGPHD11 people	88🔒	Utrecht	NL	Seed–Late Stage	$1.1M – $32.4M	+ Add to CRM
LI Limburgse Reconversie Maatschappij DBDEKWPS11 people	88🔒	Hasselt	BE	Seed–Late Stage	$27K – $10.8M	+ Add to CRM
AN Ananda Impact Ventures FEJWBKZP10 people	88🔒	Munich	DE	Pre-Seed–Series A	$540K – $3.2M	+ Add to CRM
MA Matterwave Ventures BKCRIKRG10 people	88🔒	Munich	DE	Seed–Series B	$1.1M – $10.8M	+ Add to CRM
SW Swisscom Ventures ASPLSKJM9 people	88🔒	Zürich	CH	Seed–Series B	$1M – $20M	+ Add to CRM
BI Bioqube Ventures DDDRJENV9 people	88🔒	Brussels	BE	Seed–Late Stage	$108K – $6.5M	+ Add to CRM
HI Hi Inov PDVGJJVR8 people	88🔒	Lyon	FR	Seed–Series B	$540K – $10.8M	+ Add to CRM
6 6 Degrees Capital FCLSTDTO8 people	88🔒	London	BE	Seed–Series B	$1.1M – $5.4M	+ Add to CRM

Curiosity VC

BeneluxSeed–Series A

VBHKMBH22 people

Elaia

ParisSeed–Growth$108K – $1.6M

ACEPFDMR11 people

XAnge

ParisPre-Seed–Series B

Moonfire Ventures

St Peter Port, GuernseySeed–Series A

MLAGMAAP14 people

Angelwise

Seed–Series A$200K – $600K

JVMMMBG24 people

Newion

AmsterdamSeed–Late Stage$1.1M – $11M

JVPPFCMD10 people

Cottonwood Technology Fund

DenverPre-Seed–Growth$1M – $3M

ALDBLRPC12 people

Ventech

ParisSeed–Growth$540K – $5.4M

ACASCCCH10 people

Motive Partners

New YorkPre-Seed–Late Stage$1M – $10M

Finch Capital

AmsterdamSeries A–Growth$5.4M – $16.2M

AGFRMBRV9 people

Atomico

LondonSeed–Late Stage

NZAHBBCB11 people

ENGIE New Ventures

ParisSeed–Late Stage$1.1M – $5.4M

JBCCLRSP6 people

Fortino Capital

AntwerpSeed–Late Stage$540K – $32.4M

DSFVIKJV11 people

b2venture

BerlinPre-Seed–Late Stage$270K – $5.4M

FSAGCSGJ11 people

Dawn Capital LLP

LondonSeries A–Series B$317.5K – $6.3M

DCEPHOHM11 people

EQT Life Sciences

AmsterdamSeries A–Late Stage$10.8M – $64.8M

APFVFAJR11 people

Gilde Healthcare

UtrechtSeed–Late Stage$1.1M – $32.4M

AFEDGPHD11 people

Limburgse Reconversie Maatschappij

HasseltSeed–Late Stage$27K – $10.8M

DBDEKWPS11 people

Ananda Impact Ventures

MunichPre-Seed–Series A$540K – $3.2M

FEJWBKZP10 people

Matterwave Ventures

MunichSeed–Series B$1.1M – $10.8M

BKCRIKRG10 people

Swisscom Ventures

ZürichSeed–Series B$1M – $20M

ASPLSKJM9 people

Bioqube Ventures

BrusselsSeed–Late Stage$108K – $6.5M

DDDRJENV9 people

Hi Inov

LyonSeed–Series B$540K – $10.8M

PDVGJJVR8 people

6 Degrees Capital

LondonSeed–Series B$1.1M – $5.4M

FCLSTDTO8 people

Data sourced from public filings and firms' own websites — see our methodology.